Studies have shown that impaired insulin signaling pathways regulate amyloid precursor protein processing (Adlerz et al., 2007) and Aβ clearance by blocking PI3K/AKT pathway, which may partially explain why diabetic patients are susceptible to AD (Sun et al., 2020). Here, AKT1 is linked to Alzheimer disease.